A detailed history of Charles Schwab Investment Management Inc transactions in Dyadic International Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 16,336 shares of DYAI stock, worth $27,771. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,336
Previous 16,336 -0.0%
Holding current value
$27,771
Previous $24,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$1.56 - $2.38 $25,484 - $38,879
16,336 New
16,336 $31,000
Q2 2021

Aug 16, 2021

SELL
$3.35 - $5.67 $148,750 - $251,765
-44,403 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$4.75 - $6.87 $17,242 - $24,938
-3,630 Reduced 7.56%
44,403 $244,000
Q3 2020

Nov 13, 2020

SELL
$7.22 - $9.11 $18,678 - $23,567
-2,587 Reduced 5.11%
48,033 $364,000
Q2 2020

Aug 14, 2020

BUY
$4.93 - $10.26 $249,556 - $519,361
50,620 New
50,620 $439,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $48.3M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.